Similar Search Results

A new look at the returns and risks to pharmaceutical R&D

Grabowski, Henry G. - In: Management science : journal of the Institute for … 36 (1990) 7, pp. 804-821

Persistent link: https://www.econbiz.de/10001093354

Dynamic impact of uncertainty on R&D cooperation formation and research performance : evidence from the bio-pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - In: Research policy : policy, management and economic … 46 (2017) 7, pp. 1255-1271

Persistent link: https://www.econbiz.de/10011844415

Are ex ante and ex post licensing agreements useful instruments to lessen uncertainty in R&D?

Siebert, Ralph - 2013

In the last decades, technologies became more complex which increased the degree of uncertainty in R&D. To overcome the uncertainty, firms frequently engage in R&D collaborations, e.g., Research Joint Ventures (RJVs), and licensing agreements. While RJVs are well explored in the literature, very...

Persistent link: https://www.econbiz.de/10010223406

Uncertain innovation with uncertain product durability

Goel, Rajeev K. - In: Applied economics letters 13 (2006) 13, pp. 829-834

Persistent link: https://www.econbiz.de/10003385708

Patently Uncertain

Cahoy, Daniel R. - 2019

Innovation is an inherently uncertain process. Success is typically coupled with risk and we can only hope that those … with great ideas will persevere. To encourage innovation, society reduces some of the innovation risk through structures … addressed by legal reform, while the others are actually essential to a healthy innovation system. The article concludes with …

Persistent link: https://www.econbiz.de/10012891073

Does tax uncertainty affect firm innovation speed?

Chen, Wanyi; Jin, Rong - In: Technovation : the international journal of … 125 (2023), pp. 1-22

Persistent link: https://www.econbiz.de/10014487411

Risk, duration, and capital budgeting : new evidence on some old questions

Cornell, Bradford - In: The journal of business : B 72 (1999) 2, pp. 183-200

Persistent link: https://www.econbiz.de/10001364030

Price-cap regulation, uncertainty and the price evolution of new pharmaceuticals

Shajarizadeh, Ali; Hollis, Aidan - In: Health economics 24 (2015) 8, pp. 966-977

Persistent link: https://www.econbiz.de/10011318463

Incorporation technical risk in compound real option models to value a pharmaceutical R&D licensing opportunity

Cassimon, Danny; De Backer, Manu; Engelen, Peter-Jan; … - In: Research policy : policy, management and economic … 40 (2011) 9, pp. 1200-1216

Persistent link: https://www.econbiz.de/10009379464

Risk-sharing agreements in pharmaceutical markets

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo; … - In: Estudios de economía aplicada : revista promovida por … 31 (2013) 2, pp. 359-378

Persistent link: https://www.econbiz.de/10010207164

1
2
3
4
5
6
7
8
9
10
Next
Last